Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Vaishampayan, Ulka N"'
Autor:
Wong RL; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Ferris LA; Department of Medicine, University of Washington, Seattle, Washington, USA., Do OA; Department of Medicine, University of Washington, Seattle, Washington, USA., Holt SK; Department of Urology, University of Washington, Seattle, Washington, USA., Ramos JD; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Crabb SJ; Cancer Sciences Unit, University of Southampton, Southampton, United Kingdom., Sternberg CN; Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, New York, USA., Bellmunt J; Hospital Del Mar, Barcelona, Spain., Ladoire S; Georges-François Leclerc Cancer Center, Dijon, France., De Giorgi U; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRCCS, Meldola, Italy., Harshman LC; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Vaishampayan UN; Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA., Necchi A; Fondazione IRCCS Instituto Nazionale dei Tumori, Milan, Italy., Srinivas S; Stanford University, Palo Alto, California, USA., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California, USA., Niegisch G; Department of Urology, Medical Faculty, Heinrich-Heine-University, Germany., Dorff TB; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Galsky MD; Mount Sinai Medical Center, New York, New York, USA., Yu EY; Department of Medicine, University of Washington, Seattle, Washington, USA.; Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Publikováno v:
The oncologist [Oncologist] 2021 Dec; Vol. 26 (12), pp. 1026-1034. Date of Electronic Publication: 2021 Aug 17.
Autor:
Do OA; School of Medicine, University of Washington School of Medicine, Seattle, WA., Ferris LA; School of Medicine, University of Washington School of Medicine, Seattle, WA., Holt SK; Department of Urology, University of Washington Medical Center, Seattle, WA., Ramos JD; Seagen Inc, Bothell, WA., Harshman LC; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Plimack ER; Division of Genitourinary Medical Oncology, Department of Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA., Crabb SJ; University of Southampton, Clinical Trials Unit, MP131, Southampton General Hospital, Southampton, Hants, United Kingdom., Pal SK; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA., De Giorgi U; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola FC, Italy., Ladoire S; Georges Francois Leclerc Cancer Center INSERM U1231, Dijon, France., Baniel J; Department of Urology, Rabin Medical Center, Tel Aviv University, Petah Tikva, Israel., Necchi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Vaishampayan UN; Department of Internal Medicine/Oncology, University of Michigan, Ann Arbor, MI., Bamias A; Department of Internal Medicine, National and Kapodistrian University of Athens, Athens, Greece., Bellmunt J; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, MA., Srinivas S; Department of Medicine/Oncology, Stanford Cancer Institute, Palo Alto, CA., Dorff TB; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA., Galsky MD; Department of Medicine, Division of Oncology, Mount Sinai Hospital, New York, NY., Yu EY; Division of Oncology, Department of Medicine, University of Washington, Seattle Cancer Care Alliance, Seattle, WA. Electronic address: evanyu@uw.edu.
Publikováno v:
Clinical genitourinary cancer [Clin Genitourin Cancer] 2021 Apr; Vol. 19 (2), pp. 125-134. Date of Electronic Publication: 2020 Nov 12.
Autor:
Grivas P; University of Washington, Seattle, WA, USA., Lalani AA; Juravinski Cancer Centre, McMaster University, Hamilton, Canada., Pond GR; McMaster University, Hamilton, Canada., Nagy RJ; Guardant Health Inc., Redwood City, CA, USA., Faltas B; Weill-Cornell Medicine, New York, NY, USA., Agarwal N; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Gupta SV; University of Utah Huntsman Cancer Institute, Salt Lake City, UT, USA., Drakaki A; David Geffen School of Medicine, UCLA, Los Angeles, CA, USA., Vaishampayan UN; Karmanos Cancer Center, Wayne State University, Detroit, MI, USA., Wang J; University of Arizona Cancer Center, Phoenix, AZ, USA., Barata PC; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Gopalakrishnan D; Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Naik G; University of Alabama at Birmingham, Birmingham, AL, USA., McGregor BA; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Kiedrowski LA; Guardant Health Inc., Redwood City, CA, USA., Lanman RB; Guardant Health Inc., Redwood City, CA, USA., Sonpavde GP; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: gurup_sonpavde@dfci.harvard.edu.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2020 Oct; Vol. 3 (5), pp. 695-699. Date of Electronic Publication: 2019 Mar 09.
Autor:
Moschini M; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland. Electronic address: marco.moschini87@gmail.com., Xylinas E; Cochin Hospital, APHP, Paris Descartes University, Paris, France., Zamboni S; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland., Mattei A; Klinik für Urologie, Luzerner Kantonsspital, Lucerne, Switzerland., Niegisch G; Department of Urology, Heinrich-Heine University, Düsseldorf, Germany., Yu EY; Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA, USA., Bamias A; National & Kapodistrian University of Athens, Athens, Greece., Agarwal N; Huntsman Cancer Institute at the University of Utah, Salt Lake, UT, USA., Sridhar SS; Cancer Clinical Research Unit (CCRU), Princess Margaret Cancer Centre, University Health Network, Toronto, Canada., Sternberg CN; Weill Cornell Medicine and NewYork-Presbyterian Hospital, New York, NY, USA., Vaishampayan UN; Karmanos Cancer Institute, Detroit, MI, USA., Rosenberg JE; Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Bellmunt J; PSMAR-IMIM Hospital del Mar Medical Research Institute, Barcelona, Spain., Galsky MD; Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY, USA., Montorsi F; Urological Research Institute (URI), Unit of Urology, IRCCS Ospedale San Raffaele, Vita-Salute San Raffaele University, Milan, Italy., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Publikováno v:
European urology oncology [Eur Urol Oncol] 2020 Feb; Vol. 3 (1), pp. 94-101. Date of Electronic Publication: 2019 Jul 13.
Autor:
Martini A; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York., Jia R; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Ferket BS; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Waingankar N; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York.; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Plimack ER; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Crabb SJ; University of Southampton, Southampton, United Kingdom., Harshman LC; Dana-Farber Cancer Institute, Boston, Massachusetts., Yu EY; University of Washington, Seattle, Washington., Powles T; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, New York., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, California., Vaishampayan UN; Karmanos Cancer Center, Wayne State University, Detroit, Michigan., Necchi A; National Institute for Tumors, Milan, Italy., Wiklund NP; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York., Mehrazin R; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York., Mazumdar M; Institute for Healthcare Delivery Science, Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, New York., Sfakianos JP; Department of Urology, Icahn School of Medicine at Mount Sinai, New York, New York., Galsky MD; Division of Hematology and Oncology, Department of Medicine, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York.
Publikováno v:
Cancer [Cancer] 2019 Sep 15; Vol. 125 (18), pp. 3155-3163. Date of Electronic Publication: 2019 May 31.
Autor:
Sonpavde GP; Dana-Farber Cancer Institute, Boston, Massachusetts., Mariani L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lo Vullo S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Raggi D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Giannatempo P; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Bamias A; University of Athens, Athens, Greece., Crabb SJ; University of Southampton, Southampton., Bellmunt J; Hospital del Mar Medical Research Institute, Barcelona, Spain., Yu EY; University of Washington, Seattle, Washington., Niegisch G; Department of Urology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany., Vaishampayan UN; Karmanos Cancer Center, Wayne State University, Detroit, Michigan., Theodore C; Hospital Foch, Suresnes, France., Berthold DR; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Srinivas S; Stanford University, Stanford, California., Sridhar SS; Princess Margaret Hospital Cancer Center, Toronto, Ontario, Canada., Plimack ER; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, New York., Powles T; Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Galsky MD; Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, New York, New York., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: andrea.necchi@istitutotumori.mi.it.
Publikováno v:
The Journal of urology [J Urol] 2018 Dec; Vol. 200 (6), pp. 1207-1214. Date of Electronic Publication: 2018 Sep 04.
Autor:
Agarwal N; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Pal SK; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, California., Hahn AW; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Nussenzveig RH; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Pond GR; Department of Oncology, McMaster University, Hamilton, Ontario, Canada., Gupta SV; Division of Oncology, Department of Internal Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Wang J; Genitourinary Oncology Section, University of Arizona Cancer Center at Dignity Health, St. Joseph's Hospital and Medical Center, Phoenix, Arizona., Bilen MA; Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, Georgia., Naik G; Department of Oncology, University of Alabama at Birmingham, Birmingham, Alabama., Ghatalia P; Department of Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania., Hoimes CJ; Division of Hematology/Oncology, Case Western Reserve University, Seidman Cancer Center, Cleveland, Ohio., Gopalakrishnan D; Department of Hospital Medicine, Cleveland Clinic, Cleveland, Ohio., Barata PC; Division of Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington., Drakaki A; Department of Hematology/Oncology, University of California at Los Angeles Medical Center, Los Angeles, California., Faltas BM; Department of Medical Oncology, Weill-Cornell Medical College, New York City, New York., Kiedrowski LA; Guardant Health Inc, Redwood, California., Lanman RB; Guardant Health Inc, Redwood, California., Nagy RJ; Guardant Health Inc, Redwood, California., Vogelzang NJ; Department of Oncology, Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada., Boucher KM; Division of Biostatistics, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah., Vaishampayan UN; Department of Oncology, Karmanos Cancer Institute, Detroit, Michigan., Sonpavde G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Grivas P; Division of Oncology, Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Publikováno v:
Cancer [Cancer] 2018 May 15; Vol. 124 (10), pp. 2115-2124. Date of Electronic Publication: 2018 Mar 08.
Autor:
Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy. Electronic address: andrea.necchi@istitutotumori.mi.it., Sonpavde G; UAB Comprehensive Cancer Center, Birmingham, AL, USA., Lo Vullo S; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Giardiello D; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy., Bamias A; University of Athens, Athens, Greece., Crabb SJ; University of Southampton, Southampton, UK., Harshman LC; Dana-Farber Cancer Institute, Boston, MA, USA., Bellmunt J; Dana-Farber Cancer Institute, Boston, MA, USA., De Giorgi U; IRCCS Istituto Scientifico Romagnolo per lo studio e la Cura dei Tumori, Meldola, Italy., Sternberg CN; San Camillo Forlanini Hospital, Rome, Italy., Cerbone L; San Camillo Forlanini Hospital, Rome, Italy., Ladoire S; Center Georges-François Leclerc, Dijon, France., Wong YN; Fox Chase Cancer Center, Philadelphia, PA, USA., Yu EY; University of Washington, Seattle, WA, USA., Chowdhury S; Guy's and St. Thomas' Hospital, London, UK., Niegisch G; Heinrich-Heine-University, Medical Faculty, Department of Urology, Düsseldorf, Germany., Srinivas S; Stanford University School of Medicine, Stanford, CA, USA., Vaishampayan UN; Karmanos Cancer Institute, Detroit, MI, USA., Pal SK; City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Agarwal N; University of Utah, Salt Lake City, UT, USA., Alva A; University of Michigan, Ann Arbor, MI, USA., Baniel J; Rabin Medical Center, Petach Tikva, Israel., Golshayan AR; Medical University of South Carolina, Charleston, SC, USA., Morales-Barrera R; Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital, Universitat Autonoma de Barcelona, Barcelona, Spain., Bowles DW; Denver Veterans Affairs Medical Center, Eastern Colorado Health Care System, Denver, CO, USA., Milowsky MI; University of North Carolina at Chapel Hill, Lineberger Comprehensive Cancer Center, NC, USA., Theodore C; Hopital Foch, Suresnes, France., Berthold DR; Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland., Daugaard G; Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark., Sridhar SS; Princess Margaret Hospital, University Health Network, Toronto, Canada., Powles T; Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK., Rosenberg JE; Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Galsky MD; Mount Sinai School of Medicine, Tisch Cancer Institute, New York, NY, USA., Mariani L; Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.
Publikováno v:
European urology [Eur Urol] 2017 Feb; Vol. 71 (2), pp. 281-289. Date of Electronic Publication: 2016 Oct 08.
Autor:
Balar AV; Genitourinary Cancers Program, Perlmutter Cancer Center, New York University Langone Medical Center, New York, NY, USA. Electronic address: arjun.balar@nyumc.org., Galsky MD; The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Rosenberg JE; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Powles T; Barts Cancer Institute ECMC, Barts Health and the Royal Free NHS Trust, Queen Mary University of London, London, UK., Petrylak DP; Smilow Cancer Center, Yale University, New Haven, CT, USA., Bellmunt J; Lank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Loriot Y; Département de médecine oncologique, Université Paris-Saclay and Gustave Roussy, Villejuif, France., Necchi A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Hoffman-Censits J; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA., Perez-Gracia JL; Department of Oncology, Clínica Universidad de Navarra, University of Navarra, Pamplona, Navarre, Spain., Dawson NA; Medstar Georgetown University Hospital, Lombardi Comprehensive Cancer Center, Washington, DC, USA., van der Heijden MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Dreicer R; Division of Hematology/Oncology, University of Virginia School of Medicine, Charlottesville, VA, USA., Srinivas S; Division of Oncology/Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA., Retz MM; Department of Urology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany., Joseph RW; Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL, USA., Drakaki A; Department of Medicine, Division of Hematology and Oncology and Institute of Urologic Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA., Vaishampayan UN; Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA., Sridhar SS; Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, Toronto, ON, Canada., Quinn DI; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA, USA., Durán I; Department of Medical Oncology, Hospital Universitario Virgen del Rocío and Institute of Biomedicine of Seville, Seville, Spain., Shaffer DR; New York Oncology Hematology, Albany, NY, USA., Eigl BJ; British Columbia Cancer Agency, British Columbia, Vancouver, Canada., Grivas PD; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA., Yu EY; Division of Oncology, Department of Medicine, University of Washington and Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Li S; Genentech, South San Francisco, CA, USA., Kadel EE 3rd; Genentech, South San Francisco, CA, USA., Boyd Z; Genentech, South San Francisco, CA, USA., Bourgon R; Genentech, South San Francisco, CA, USA., Hegde PS; Genentech, South San Francisco, CA, USA., Mariathasan S; Genentech, South San Francisco, CA, USA., Thåström A; Genentech, South San Francisco, CA, USA., Abidoye OO; Genentech, South San Francisco, CA, USA., Fine GD; Genentech, South San Francisco, CA, USA., Bajorin DF; Genitourinary Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
Lancet (London, England) [Lancet] 2017 Jan 07; Vol. 389 (10064), pp. 67-76. Date of Electronic Publication: 2016 Dec 08.
Autor:
Ramos JD; University of Washington, Seattle, Washington., Casey MF; Icahn School of Medicine at Mount Sinai, New York, New York., Crabb SJ; University of Southampton, Southampton, England., Bamias A; National and Kapodistrian University of Athens, Athens, Greece., Harshman LC; Dana Farber Cancer Institute, Boston, Massachusetts., Wong YN; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Bellmunt J; Hospital del Mar, Barcelona, Spain., De Giorgi U; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Ladoire S; Georges François Leclerc Center, Dijon, France.; Université de Bourgogne, Dijon, France., Powles T; Barts and the London School of Medicine, London, England., Pal SK; City of Hope, Duarte, California., Niegisch G; Heinrich-Heine-University, Düsseldorf, Germany., Recine F; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy., Alva A; University of Michigan, Ann Arbor, Michigan., Agarwal N; University of Utah, Salt Lake City, Utah., Necchi A; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Vaishampayan UN; Karmanos Cancer Institute, Detroit, Michigan., Rosenberg JE; Memorial Sloan Kettering Cancer Center, New York, New York., Galsky MD; Icahn School of Medicine at Mount Sinai, New York, New York., Yu EY; University of Washington, Seattle, Washington.
Publikováno v:
Cancer medicine [Cancer Med] 2017 Jan; Vol. 6 (1), pp. 186-194. Date of Electronic Publication: 2016 Dec 20.